Qianhui Zhu

State Key Laboratory Of Microbial Diversity And Innovative Utilization
Beijing, 100101, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Corrigendum to "Reconstitution of gut microbiota by medicinal plant isoflavones ameliorates heart failure with preserved ejection fraction" [Pharmacol. Res., Vol 228, June 2026, 108199].

Corrigendum to "Reconstitution of gut microbiota by medicinal plant isoflavones ameliorates heart failure with preserved ejection fraction" [Pharmacol. Res., Vol 228, June 2026, 108199].

Journal: Pharmacological research
Published: June 02, 2026

Designed nanoparticles enable multivalent display of influenza HA to drive rapid, potent, durable, and cross-reactive antibody responses.

Designed nanoparticles enable multivalent display of influenza HA to drive rapid, potent, durable, and cross-reactive antibody responses.

Journal: Protein & cell
Published: April 30, 2026

Reconstitution of gut microbiota by medicinal plant isoflavones ameliorates heart failure with preserved ejection fraction.

Reconstitution of gut microbiota by medicinal plant isoflavones ameliorates heart failure with preserved ejection fraction.

Journal: Pharmacological research
Published: January 27, 2026

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron.

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron.

Journal: Cell
Published: November 25, 2025

Investigating the effects and underlying mechanisms of glycosylation sites on the immunogenicity of COVID-19 vaccines.

Investigating the effects and underlying mechanisms of glycosylation sites on the immunogenicity of COVID-19 vaccines.

Journal: Signal transduction and targeted therapy
Published: May 06, 2025

Enhancing RBD exposure and S1 shedding by an extremely conserved SARS-CoV-2 NTD epitope.

Enhancing RBD exposure and S1 shedding by an extremely conserved SARS-CoV-2 NTD epitope.

Journal: Signal transduction and targeted therapy
Published: March 29, 2024

Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity.

Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity.

Journal: National science review
Published: March 07, 2024

Deletion of V483 in the spike confers evolutionary advantage on SARS-CoV-2 for human adaptation and host-range expansion after a prolonged pandemic.

Deletion of V483 in the spike confers evolutionary advantage on SARS-CoV-2 for human adaptation and host-range expansion after a prolonged pandemic.

Journal: Cell research
Published: February 21, 2024

Large-scale genomic survey and characterization of mcr genes carried by foodborne Cronobacter isolates.

Large-scale genomic survey and characterization of mcr genes carried by foodborne Cronobacter isolates.

Journal: mSystems
Published: September 11, 2023

Plasmer: an Accurate and Sensitive Bacterial Plasmid Prediction Tool Based on Machine Learning of Shared k-mers and Genomic Features.

Plasmer: an Accurate and Sensitive Bacterial Plasmid Prediction Tool Based on Machine Learning of Shared k-mers and Genomic Features.

Journal: Microbiology spectrum
Published: May 16, 2023

Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75.

Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75.

Journal: Cell host & microbe
Published: August 15, 2022

Genomic Characterization of a Uropathogenic Escherichia coli ST405 Isolate Harboring bla CTX-M-15-Encoding IncFIA-FIB Plasmid, bla CTX-M-24-Encoding IncI1 Plasmid, and Phage-Like Plasmid.

Genomic Characterization of a Uropathogenic Escherichia coli ST405 Isolate Harboring bla CTX-M-15-Encoding IncFIA-FIB Plasmid, bla CTX-M-24-Encoding IncI1 Plasmid, and Phage-Like Plasmid.

Journal: Frontiers in microbiology
Published: December 29, 2021
Showing 1-12 of 20

Last Updated: 09/26/2026